Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Prepaid Assets (2016 - 2025)

Anika Therapeutics (ANIK) has disclosed Prepaid Assets for 16 consecutive years, with $3.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Prepaid Assets fell 38.11% to $3.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $3.4 million, a 38.11% decrease, with the full-year FY2025 number at $3.4 million, down 38.11% from a year prior.
  • Prepaid Assets was $3.4 million for Q4 2025 at Anika Therapeutics, down from $5.1 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $10.5 million in Q1 2022 to a low of $3.4 million in Q4 2025.
  • A 5-year average of $7.4 million and a median of $7.8 million in 2023 define the central range for Prepaid Assets.
  • Peak YoY movement for Prepaid Assets: skyrocketed 70.49% in 2021, then crashed 38.11% in 2025.
  • Anika Therapeutics' Prepaid Assets stood at $8.3 million in 2021, then rose by 6.5% to $8.8 million in 2022, then dropped by 15.31% to $7.5 million in 2023, then decreased by 26.51% to $5.5 million in 2024, then plummeted by 38.11% to $3.4 million in 2025.
  • Per Business Quant, the three most recent readings for ANIK's Prepaid Assets are $3.4 million (Q4 2025), $5.1 million (Q3 2025), and $5.3 million (Q2 2025).